Mirum Pharmaceuticals
MIRM
86 hedge funds and large institutions have $396M invested in Mirum Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 27 increasing their positions, 20 reducing their positions, and 10 closing their positions.
140% more first-time investments, than exits
New positions opened: 24 | Existing positions closed: 10
35% more repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 20
22% more call options, than puts
Call options by funds: $787K | Put options by funds: $643K
18% more funds holding
Funds holding: 73 → 86 (+13)
4.48% more ownership
Funds ownership: 76.5% → 80.98% (+4.5%)
15% less capital invested
Capital invested by funds: $465M → $396M (-$69.3M)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
+$7.53M |
| 2 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
+$5.26M |
| 3 |
SAM
Silvercrest Asset Management
New York
|
+$4.45M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$2.65M |
| 5 |
BlackRock
New York
|
+$2.51M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BBA
Baker Bros. Advisors
New York
|
-$12.9M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$2.9M |
| 3 |
Millennium Management
New York
|
-$1.32M |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$987K |
| 5 |
AA
ALPS Advisors
Denver,
Colorado
|
-$745K |
MIRM Hedge Fund Activity: Q4 2021 in Review
86 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Mirum Pharmaceuticals (MIRM) for Q4 2021, worth a combined $396M — down 15% from $465M a quarter earlier.
Buyers outnumbered sellers: 24 funds opened new MIRM positions and 10 closed out — a net gain of 14 holders — while 27 added to existing stakes and 20 trimmed.
The largest buyer was Franklin Resources, opening a new position worth an estimated $7.53M. The largest seller was Baker Bros. Advisors, exiting entirely with an estimated $12.9M sold.
- 86 institutional investors held Mirum Pharmaceuticals (MIRM) as of Q4 2021, up from 73 in Q3 2021.
- Funds reported $396M of Mirum Pharmaceuticals stock for Q4 2021, down 15% quarter-over-quarter.
- 24 funds opened new Mirum Pharmaceuticals positions in Q4 2021 and 10 closed out, a net change of +14 holders.
- The largest Mirum Pharmaceuticals buyer in Q4 2021 was Franklin Resources, an estimated $7.53M added.
- The largest Mirum Pharmaceuticals seller in Q4 2021 was Baker Bros. Advisors, an estimated $12.9M sold.
Based on aggregated 13F filings for Q4 2021.